Mark Schoenberg

1PUBLICATIONS
2CO-AUTHORS
Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 25, 2026
UGN-102 for Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer: 24-Month Duration of Response Results From the Phase 3 ENVISION Trial.

Sandip M Prasad, Dimitar Shishkov, Nikola Vladimirov Mihaylov

Pageof 1

Frequent Collaborators

1 joint publications

Max Kates

1 joint publications

Michael J Louie